{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:44:35Z","timestamp":1772840675055,"version":"3.50.1"},"reference-count":224,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kazan Federal University Strategic Academic Leadership Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The ability to detect and monitor amyloid deposition in the brain using non-invasive imaging techniques provides valuable insights into the early diagnosis and progression of Alzheimer\u2019s disease and helps to evaluate the efficacy of potential treatments. Magnetic resonance imaging (MRI) is a widely available technique offering high-spatial-resolution imaging. It can be used to visualize amyloid deposits with the help of amyloid-binding diagnostic agents injected into the body. In recent years, a number of amyloid-targeted MRI probes have been developed, but none of them has entered clinical practice. We review the advances in the field and deduce the requirements for the molecular structure and properties of a diagnostic probe candidate. These requirements make up the base for the rational design of MRI-active small molecules targeting amyloid deposits. Particular attention is paid to the novel cryo-EM structures of the fibril aggregates and their complexes, with known binders offering the possibility to use computational structure-based design methods. With continued research and development, MRI probes may revolutionize the diagnosis and treatment of neurodegenerative diseases, ultimately improving the lives of millions of people worldwide.<\/jats:p>","DOI":"10.3390\/ijms241311152","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T01:41:36Z","timestamp":1688694096000},"page":"11152","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits"],"prefix":"10.3390","volume":"24","author":[{"given":"Alena","family":"Nikiforova","sequence":"first","affiliation":[{"name":"Chemical Institute, Kazan Federal University, Kremlevskaya 18, 420008 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0438-5991","authenticated-orcid":false,"given":"Igor","family":"Sedov","sequence":"additional","affiliation":[{"name":"Chemical Institute, Kazan Federal University, Kremlevskaya 18, 420008 Kazan, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"(2020). 2020 Alzheimer\u2019s Disease Facts and Figures. Alzheimer\u2019s Dement., 16, 391\u2013460.","DOI":"10.1002\/alz.12068"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Yeo, S.K., Shepelytskyi, Y., Grynko, V., and Albert, M.S. (2020). Molecular Imaging of Fluorinated Probes for Tau Protein and Amyloid-\u03b2 Detection. Molecules, 25.","DOI":"10.3390\/molecules25153413"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer\u2019s Disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a Biological Definition of Alzheimer\u2019s Disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The Diagnosis of Dementia Due to Alzheimer\u2019s Disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.12688\/f1000research.14506.1","article-title":"Current Understanding of Alzheimer\u2019s Disease Diagnosis and Treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Research"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF Biomarkers of Alzheimer\u2019s Disease Concord with Amyloid-\u03b2 PET and Predict Clinical Progression: A Study of Fully Automated Immunoassays in BioFINDER and ADNI Cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/NRL.0b013e31826a998d","article-title":"New Criteria for Alzheimer Disease and Mild Cognitive Impairment: Implications for the Practicing Clinician","volume":"18","author":"Budson","year":"2012","journal-title":"Neurologist"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0197-4580(94)90032-9","article-title":"Morphological Criteria for the Recognition of Alzheimer\u2019s Disease and the Distribution Pattern of Cortical Changes Related to This Disorder","volume":"15","author":"Braak","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s Disease: The Amyloid Cascade Hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The Amyloid Hypothesis of Alzheimer\u2019s Disease: Progress and Problems on the Road to Therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The Amyloid Hypothesis of Alzheimer\u2019s Disease at 25 Years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical Trials of New Drugs for Alzheimer Disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer\u2019s Disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_15","first-page":"27","article-title":"Biomarkers in Alzheimer\u2019s Disease","volume":"2","author":"Janeiro","year":"2021","journal-title":"Adv. Lab. Med. Adv. En Med. Lab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41598-017-05285-1","article-title":"Contrast-Enhanced MR Microscopy of Amyloid Plaques in Five Mouse Models of Amyloidosis and in Human Alzheimer\u2019s Disease Brains","volume":"7","author":"Dudeffant","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"(2021). 2021 Alzheimer\u2019s Disease Facts and Figures. Alzheimer\u2019s Dement., 17, 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population Estimate of People with Clinical Alzheimer\u2019s Disease and Mild Cognitive Impairment in the United States (2020\u20132060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1021\/acssensors.0c01101","article-title":"Strategies for the Molecular Imaging of Amyloid and the Value of a Multimodal Approach","volume":"5","author":"Kaur","year":"2020","journal-title":"ACS Sens."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7462014","DOI":"10.1155\/2016\/7462014","article-title":"Insight into the Molecular Imaging of Alzheimer\u2019s Disease","volume":"2016","author":"Arora","year":"2016","journal-title":"Int. J. Biomed. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1479-8301.2012.00409.x","article-title":"Molecular Imaging of Dementia: Molecular Imaging for Dementia","volume":"12","author":"Mori","year":"2012","journal-title":"Psychogeriatrics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2174\/156802607782507402","article-title":"Recent Advances in the Development of Amyloid Imaging Agents","volume":"7","author":"Furumoto","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1039\/C3CS60430F","article-title":"PET\/SPECT Imaging Agents for Neurodegenerative Diseases","volume":"43","author":"Zhu","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/WCO.0b013e3283168e1a","article-title":"The Future of Amyloid-Beta Imaging: A Tale of Radionuclides and Tracer Proliferation","volume":"21","author":"Klunk","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Uzuegbunam, B.C., Librizzi, D., and Hooshyar Yousefi, B. (2020). PET Radiopharmaceuticals for Alzheimer\u2019s Disease and Parkinson\u2019s Disease Diagnosis, the Current and Future Landscape. Molecules, 25.","DOI":"10.3390\/molecules25040977"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.ccr.2012.03.035","article-title":"Diagnostic Imaging of Alzheimer\u2019s Disease with Copper and Technetium Complexes","volume":"256","author":"Hickey","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1039\/C4CS00026A","article-title":"Metal Complexes Designed to Bind to Amyloid-\u03b2 for the Diagnosis and Treatment of Alzheimer\u2019s Disease","volume":"43","author":"Hayne","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-4939-7404-7_16","article-title":"Computational Modeling of Diagnostic Imaging Agents for Alzheimer\u2019s Disease: Molecular Imaging Agents for the In Vivo Detection of Amyloid Plaques in Alzheimer\u2019s Disease","volume":"Volume 132","author":"Roy","year":"2018","journal-title":"Computational Modeling of Drugs against Alzheimer\u2019s Disease"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11819","DOI":"10.1021\/acs.chemrev.9b00404","article-title":"Interrogating Amyloid Aggregates Using Fluorescent Probes","volume":"119","author":"Aliyan","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.acc.2020.08.008","article-title":"Advances in Fluorescent Probes for Detection and Imaging of Amyloid-\u03b2 Peptides in Alzheimer\u2019s Disease","volume":"Volume 103","author":"Zhang","year":"2021","journal-title":"Advances in Clinical Chemistry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/138920311795860151","article-title":"Small Molecule Fluorescent Probes for the Detection of Amyloid Self-Assembly In Vitro and In Vivo","volume":"12","author":"Bertoncini","year":"2011","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109466","DOI":"10.1016\/j.dyepig.2021.109466","article-title":"Research Progress of Multi-Functional Fluorescent Probes for Alzheimer\u2019s Disease Monitoring","volume":"193","author":"Yang","year":"2021","journal-title":"Dye. Pigment."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"111982","DOI":"10.1016\/j.ejmech.2019.111982","article-title":"Biological Applications of near Infrared Fluorescence Dye Probes in Monitoring Alzheimer\u2019s Disease","volume":"187","author":"Gyasi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mcna.2012.12.013","article-title":"Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease","volume":"97","author":"Teipel","year":"2013","journal-title":"Med. Clin. N. Am."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neurol.2013.07.013","article-title":"Magnetic Resonance Imaging for Diagnosis of Early Alzheimer\u2019s Disease","volume":"169","author":"Colliot","year":"2013","journal-title":"Rev. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccr.2016.04.018","article-title":"Alzheimer\u2019s Disease: The Use of Contrast Agents for Magnetic Resonance Imaging to Detect Amyloid Beta Peptide inside the Brain","volume":"327\u2013328","author":"Salerno","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12154-009-0027-5","article-title":"Binding Mode of Thioflavin T and Other Molecular Probes in the Context of Amyloid Fibrils\u2014Current Status","volume":"3","author":"Groenning","year":"2010","journal-title":"J. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"BSR20181415","DOI":"10.1042\/BSR20181415","article-title":"Congo Red and Amyloids: History and Relationship","volume":"39","author":"Yakupova","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bpj.2012.07.008","article-title":"Binding of Congo Red to Amyloid Protofibrils of the Alzheimer A\u03b29\u201340 Peptide Probed by Molecular Dynamics Simulations","volume":"103","author":"Wu","year":"2012","journal-title":"Biophys. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"160696","DOI":"10.1098\/rsos.160696","article-title":"Thioflavin T as an Amyloid Dye: Fibril Quantification, Optimal Concentration and Effect on Aggregation","volume":"4","author":"Xue","year":"2017","journal-title":"R. Soc. Open Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1039\/c3cs60086f","article-title":"The Benzazole Scaffold: A SWAT to Combat Alzheimer\u2019s Disease","volume":"42","author":"Cadet","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2217\/fon.09.109","article-title":"Clinical Implications of Near-Infrared Fluorescence Imaging in Cancer","volume":"5","author":"Kosaka","year":"2009","journal-title":"Future Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fbioe.2019.00487","article-title":"Recent Progress in NIR-II Contrast Agent for Biological Imaging","volume":"7","author":"Cao","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/lio2.84","article-title":"Specimen Mapping in Head and Neck Cancer Using Fluorescence Imaging: Specimen Mapping in HNC","volume":"2","author":"Teraphongphom","year":"2017","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15257","DOI":"10.1021\/ja9047043","article-title":"Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-\u03b2 Deposits","volume":"131","author":"Ran","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1364\/BOE.458290","article-title":"Non-Invasive Visualization of Amyloid-Beta Deposits in Alzheimer Amyloidosis Mice Using Magnetic Resonance Imaging and Fluorescence Molecular Tomography","volume":"13","author":"Ren","year":"2022","journal-title":"Biomed. Opt. Express"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"131481","DOI":"10.1016\/j.snb.2022.131481","article-title":"Detection of A\u03b2 Oligomers in Early Alzheimer\u2019s Disease Diagnose by in Vivo NIR-II Fluorescence Imaging","volume":"358","author":"Li","year":"2022","journal-title":"Sens. Actuators B Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e202216351","DOI":"10.1002\/anie.202216351","article-title":"An Activatable NIR-II Fluorescent Reporter for In Vivo Imaging of Amyloid-\u03b2 Plaques","volume":"62","author":"Miao","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jnr.24188","article-title":"Fluorine-19 Magnetic Resonance Imaging Probe for the Detection of Tau Pathology in Female RTg4510 Mice","volume":"96","author":"Yanagisawa","year":"2018","journal-title":"J. Neuro Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-bioeng-071114-040723","article-title":"Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems","volume":"17","author":"Vaquero","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.semnuclmed.2003.12.002","article-title":"Positron Emission Tomography: A Review of Basic Principles, Scanner Design and Performance, and Current Systems","volume":"34","author":"Zanzonico","year":"2004","journal-title":"Semin. Nucl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"494001","DOI":"10.1088\/0957-4484\/22\/49\/494001","article-title":"Nanoparticle-Based Monitoring of Cell Therapy","volume":"22","author":"Xu","year":"2011","journal-title":"Nanotechnology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3174\/ajnr.A1175","article-title":"Brain Single-Photon Emission CT Physics Principles","volume":"29","author":"Accorsi","year":"2008","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_54","unstructured":"Du, Y., and Zaidi, H. (2019). Encyclopedia of Biomedical Engineering, Elsevier."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J. Nucl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","article-title":"Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density","volume":"72","author":"Curtis","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000339367","article-title":"Impact of Beta-Amyloid-Specific Florbetaben PET Imaging on Confidence in Early Diagnosis of Alzheimer\u2019s Disease","volume":"33","author":"Schipke","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with Florbetapir Compared with Neuropathology at Autopsy for Detection of Neuritic Amyloid-\u03b2 Plaques: A Prospective Cohort Study","volume":"11","author":"Clark","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","article-title":"Beta-Amyloid Imaging with Florbetaben","volume":"3","author":"Sabri","year":"2015","journal-title":"Clin. Transl. Imaging"},{"key":"ref_60","first-page":"25","article-title":"Performance of [18F]Flutemetamol Amyloid Imaging against the Neuritic Plaque Component of CERAD and the Current (2012) NIA-AA Recommendations for the Neuropathologic Diagnosis of Alzheimer\u2019s Disease","volume":"9","author":"Salloway","year":"2017","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.apradiso.2010.07.001","article-title":"GMP-Compliant Automated Synthesis of [18F]AV-45 (Florbetapir F 18) for Imaging \u03b2-Amyloid Plaques in Human Brain","volume":"68","author":"Yao","year":"2010","journal-title":"Appl. Radiat. Isot."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41181-020-00113-w","article-title":"A Simple and Efficient Automated Microvolume Radiosynthesis of [18F]Florbetaben","volume":"5","author":"Lisova","year":"2020","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.apradiso.2012.09.014","article-title":"Automated Synthesis of [18F]Florbetaben as Alzheimer\u2019s Disease Imaging Agent Based on a Synthesis Module System","volume":"71","author":"Wang","year":"2013","journal-title":"Appl. Radiat. Isot."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Petrov, S.A., Yusubov, M.S., Beloglazkina, E.K., and Nenajdenko, V.G. (2022). Synthesis of Radioiodinated Compounds. Classical Approaches and Achievements of Recent Years. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213789"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bc500475e","article-title":"Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes","volume":"26","author":"Jacobson","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"ref_66","first-page":"748","article-title":"Safety, Biodistribution, and Dosimetry of 123I-IMPY: A Novel Amyloid Plaque-Imaging Agent for the Diagnosis of Alzheimer\u2019s Disease","volume":"47","author":"Newberg","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.arr.2015.12.008","article-title":"Amyloid Imaging Using Fluorine-19 Magnetic Resonance Imaging (19F-MRI)","volume":"30","author":"Tooyama","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"ref_68","first-page":"433","article-title":"PET\/SPECT Molecular Imaging in Clinical Neuroscience: Recent Advances in the Investigation on CNS Diseases","volume":"5","author":"Lu","year":"2015","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","article-title":"Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers","volume":"119","author":"Wahsner","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"884495","DOI":"10.3389\/fphar.2022.884495","article-title":"A Supervised ML Applied Classification Model for Brain Tumors MRI","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12968-017-0327-9","article-title":"Reference Ranges for Cardiac Structure and Function Using Cardiovascular Magnetic Resonance (CMR) in Caucasians from the UK Biobank Population Cohort","volume":"19","author":"Petersen","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"(2006). ACCF\/ACR\/SCCT\/SCMR\/ASNC\/NASCI\/SCAI\/SIR 2006 Appropriateness Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging. J. Am. Coll. Radiol., 3, 751\u2013771.","DOI":"10.1016\/j.jacr.2006.08.008"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13244-019-0749-z","article-title":"MRI Imaging of Soft Tissue Tumours of the Foot and Ankle","volume":"10","author":"Hughes","year":"2019","journal-title":"Insights Imaging"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jmri.27368","article-title":"Primary Site Identification of Soft-Tissue Mass: Things to Know in MRI Assessment","volume":"55","author":"Aoki","year":"2022","journal-title":"Magn. Reson. Imaging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fmed.2020.00285","article-title":"Whole-Body Magnetic Resonance Imaging Assessment of Joint Inflammation in Rheumatoid Arthritis\u2014Agreement with Ultrasonography and Clinical Evaluation","volume":"7","author":"Ng","year":"2020","journal-title":"Front. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/03009740802448833","article-title":"Magnetic Resonance Imaging in the Assessment of Metacarpophalangeal Joint Disease in Early Psoriatic and Rheumatoid Arthritis","volume":"38","author":"Tanner","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mri.2009.05.042","article-title":"Evaluation of Intracranial Stenoses and Aneurysms with Accelerated 4D Flow","volume":"28","author":"Hope","year":"2010","journal-title":"Magn. Reson. Imaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4329\/wjr.v1.i1.72","article-title":"Magnetic Resonance Imaging of the Liver: New Imaging Strategies for Evaluating Focal Liver Lesions","volume":"1","author":"Coenegrachts","year":"2009","journal-title":"World J. Radiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/ijri.IJRI_226_16","article-title":"Cystic Lesions of the Pancreatico-Biliary Tree: A Schematic MRI Approach","volume":"27","author":"Halankar","year":"2017","journal-title":"Indian J. Radiol. Imaging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.2214\/AJR.05.0875","article-title":"MRI of Adenocarcinoma of the Pancreas","volume":"187","author":"Miller","year":"2006","journal-title":"Am. J. Roentgenol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12264-022-00905-x","article-title":"Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research","volume":"39","author":"Huang","year":"2023","journal-title":"Neurosci. Bull."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mrm.20196","article-title":"Visualization of ?-Amyloid Plaques in a Transgenic Mouse Model of Alzheimer\u2019s Disease Using MR Microscopy without Contrast Reagents","volume":"52","author":"Lee","year":"2004","journal-title":"Magn. Reson. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejmech.2014.10.016","article-title":"Gadolinium-Based Contrast Agents Targeted to Amyloid Aggregates for the Early Diagnosis of Alzheimer\u2019s Disease by MRI","volume":"87","author":"Bort","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/RMR.0b013e31823cd184","article-title":"Radiofrequency Coils for Musculoskeletal Magnetic Resonance Imaging","volume":"21","author":"Asher","year":"2010","journal-title":"Top. Magn. Reson. Imaging"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1021\/ja2057506","article-title":"Design of Chemical Shift-Switching 19F Magnetic Resonance Imaging Probe for Specific Detection of Human Monoamine Oxidase A","volume":"133","author":"Yamaguchi","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tibtech.2010.04.002","article-title":"de 19F MRI for Quantitative in Vivo Cell Tracking","volume":"28","author":"Srinivas","year":"2010","journal-title":"Trends Biotechnol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/cr500286d","article-title":"19F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical Applications","volume":"115","author":"Tirotta","year":"2015","journal-title":"Chem. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Boehm-Sturm, P., Mengler, L., Wecker, S., Hoehn, M., and Kallur, T. (2011). In Vivo Tracking of Human Neural Stem Cells with 19F Magnetic Resonance Imaging. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0029040"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1021\/ja503270n","article-title":"A Superfluorinated Molecular Probe for Highly Sensitive in Vivo 19F-MRI","volume":"136","author":"Tirotta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nn1422","article-title":"19F and 1H MRI Detection of Amyloid \u03b2 Plaques in Vivo","volume":"8","author":"Higuchi","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejmech.2004.02.013","article-title":"Fluoro-Substituted and 13C-Labeled Styrylbenzene Derivatives for Detecting Brain Amyloid Plaques","volume":"39","author":"Sato","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1021\/jm070085f","article-title":"Polyfluorinated Bis-Styrylbenzene \u03b2-Amyloid Plaque Binding Ligands","volume":"50","author":"Flaherty","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neures.2008.10.006","article-title":"Trifluoromethoxy-Benzylated Ligands Improve Amyloid Detection in the Brain Using 19F Magnetic Resonance Imaging","volume":"63","author":"Amatsubo","year":"2009","journal-title":"Neurosci. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.biomaterials.2010.01.142","article-title":"Relationship between the Tautomeric Structures of Curcumin Derivatives and Their A\u03b2-Binding Activities in the Context of Therapies for Alzheimer\u2019s Disease","volume":"31","author":"Yanagisawa","year":"2010","journal-title":"Biomaterials"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2011.03.071","article-title":"In Vivo Detection of Amyloid \u03b2 Deposition Using 19F Magnetic Resonance Imaging with a 19F-Containing Curcumin Derivative in a Mouse Model of Alzheimer\u2019s Disease","volume":"184","author":"Yanagisawa","year":"2011","journal-title":"Neuroscience"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3233\/JAD-131025","article-title":"Preferred Features of a Fluorine-19 MRI Probe for Amyloid Detection in the Brain","volume":"39","author":"Yanagisawa","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Yanagisawa, D., Ibrahim, N.F., Taguchi, H., Morikawa, S., Tomiyama, T., and Tooyama, I. (2021). Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid \u03b2 Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer\u2019s Disease. Molecules, 26.","DOI":"10.3390\/molecules26051362"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/cbdd.14162","article-title":"Multi-fluorine Labeled Indanone Derivatives as Potential MRI Imaging Probes for \u03b2-Amyloid Plaques","volume":"101","author":"Dai","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/acssensors.8b01216","article-title":"In Vivo and In Vitro Monitoring of Amyloid Aggregation via BSA@FGQDs Multimodal Probe","volume":"4","author":"Yousaf","year":"2019","journal-title":"ACS Sens."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/jm901039z","article-title":"18F Stilbenes and Styrylpyridines for PET Imaging of A\u03b2 Plaques in Alzheimer\u2019s Disease: A Miniperspective","volume":"53","author":"Kung","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bpj.2014.06.024","article-title":"A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations","volume":"107","author":"Carpenter","year":"2014","journal-title":"Biophys. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A Blood\u2013Brain Barrier Overview on Structure, Function, Impairment, and Biomarkers of Integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref_103","first-page":"11","article-title":"Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier","volume":"6","author":"Mikitsh","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jps.20595","article-title":"A Data Base for Partition of Volatile Organic Compounds and Drugs from Blood\/Plasma\/Serum to Brain, and an LFER Analysis of the Data","volume":"95","author":"Abraham","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/ci700100f","article-title":"Benchmarking of QSAR Models for Blood-Brain Barrier Permeation","volume":"47","author":"Konovalov","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1040838","DOI":"10.3389\/fphar.2022.1040838","article-title":"Development of QSAR Models to Predict Blood-Brain Barrier Permeability","volume":"13","author":"Faramarzi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Pinheiro, R.G.R., Coutinho, A.J., Pinheiro, M., and Neves, A.R. (2021). Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111654"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current Strategies for Brain Drug Delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","article-title":"Possible Strategies to Cross the Blood\u2013Brain Barrier","volume":"44","author":"Bellettato","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-015-0090-6","article-title":"FIBT versus Florbetaben and PiB: A Preclinical Comparison Study with Amyloid-PET in Transgenic Mice","volume":"5","author":"Yousefi","year":"2015","journal-title":"EJNMMI Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"153601211879629","DOI":"10.1177\/1536012118796297","article-title":"The Binding of BF-227-Like Benzoxazoles to Human \u03b1-Synuclein and Amyloid \u03b2 Peptide Fibrils","volume":"17","author":"Josephson","year":"2018","journal-title":"Mol. Imaging"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10334-018-0724-6","article-title":"Fluorine Polymer Probes for Magnetic Resonance Imaging: Quo Vadis?","volume":"32","author":"Jirak","year":"2019","journal-title":"Magn. Reson. Mater. Phys. Biol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiol.2019181073","article-title":"Multispectral MRI with Dual Fluorinated Probes to Track Mononuclear Cell Activity in Mice","volume":"291","author":"Chirizzi","year":"2019","journal-title":"Radiology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/acs.chemrev.1c00632","article-title":"Biological Utility of Fluorinated Compounds: From Materials Design to Molecular Imaging, Therapeutics and Environmental Remediation","volume":"122","author":"Zhang","year":"2022","journal-title":"Chem. Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1021\/acs.joc.0c00331","article-title":"Synthesis of Branched Monodisperse Oligoethylene Glycols and 19F MRI-Traceable Biomaterials through Reductive Dimerization of Azides","volume":"85","author":"Zhang","year":"2020","journal-title":"J. Org. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/s41467-019-11320-8","article-title":"Atomic Structure of PI3-Kinase SH3 Amyloid Fibrils by Cryo-Electron Microscopy","volume":"10","author":"Vettore","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"van Gils, J.H.M., van Dijk, E., Peduzzo, A., Hofmann, A., Vettore, N., Sch\u00fctzmann, M.P., Groth, G., Mouhib, H., Otzen, D.E., and Buell, A.K. (2020). The Hydrophobic Effect Characterises the Thermodynamic Signature of Amyloid Fibril Growth. PLoS Comput. Biol., 16.","DOI":"10.1371\/journal.pcbi.1007767"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jacs.1c12056","article-title":"Binding Sites of a Positron Emission Tomography Imaging Agent in Alzheimer\u2019s \u03b2-Amyloid Fibrils Studied Using 19F Solid-State NMR","volume":"144","author":"Duan","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","article-title":"Cryo-EM Structures of Tau Filaments from Alzheimer\u2019s Disease with PET Ligand APN-1607","volume":"141","author":"Shi","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1039\/D0CC01161D","article-title":"Binding Modes of Thioflavin T and Congo Red to the Fibril Structure of Amyloid-\u03b2(1\u201342)","volume":"56","author":"Frieg","year":"2020","journal-title":"Chem. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1002\/anie.201008276","article-title":"The Amyloid-Congo Red Interface at Atomic Resolution","volume":"50","author":"Soragni","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1038\/s41467-022-32797-w","article-title":"The Clinical Drug Candidate Anle138b Binds in a Cavity of Lipidic \u03b1-Synuclein Fibrils","volume":"13","author":"Antonschmidt","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","article-title":"Structure-Based Discovery of Small Molecules That Disaggregate Alzheimer\u2019s Disease Tissue Derived Tau Fibrils in Vitro","volume":"13","author":"Seidler","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Merz, G.E., Chalkley, M.J., Tan, S., Tse, E., Lee, J., Prusiner, S.B., Paras, N.A., DeGrado, W.F., and Southworth, D.R. (2022). Stacked Binding of a Small Molecule PET Tracer to Alzheimer\u2019s Tau Paired Helical Filaments. BioRxiv.","DOI":"10.1101\/2022.09.30.510175"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41467-023-38537-y","article-title":"Stacked Binding of a PET Ligand to Alzheimer\u2019s Tau Paired Helical Filaments","volume":"14","author":"Merz","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acschemneuro.6b00450","article-title":"Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of \u03b2-Amyloid and \u03b1-Synuclein Aggregates","volume":"8","author":"Watanabe","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1039\/C6NJ01703G","article-title":"Synthesis and Evaluation of Benzothiazole-Triazole and Benzothiadiazole-Triazole Scaffolds as Potential Molecular Probes for Amyloid-\u03b2 Aggregation","volume":"41","author":"Dyrager","year":"2017","journal-title":"New J. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","article-title":"Synthesis and Evaluation of 11 C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents","volume":"46","author":"Mathis","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1474-4422(11)70123-5","article-title":"Clinical Amyloid Imaging in Alzheimer\u2019s Disease","volume":"10","author":"Herholz","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejmech.2014.10.012","article-title":"Radiolabeled Bioactive Benzoheterocycles for Imaging \u03b2-Amyloid Plaques in Alzheimer\u2019s Disease","volume":"87","author":"Yang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1021\/jm300251n","article-title":"Novel 18F-Labeled Benzoxazole Derivatives as Potential Positron Emission Tomography Probes for Imaging of Cerebral \u03b2-Amyloid Plaques in Alzheimer\u2019s Disease","volume":"55","author":"Cui","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4155\/fmc-2017-0079","article-title":"Synthesis and Biological Evaluation of Curcumin Analogs as \u03b2-Amyloid Imaging Agents","volume":"9","author":"Gan","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.dyepig.2018.12.003","article-title":"A Curcumin-Based NIR Fluorescence Probe for Detection of Amyloid-Beta (A\u03b2) Plaques in Alzheimer\u2019s Disease","volume":"163","author":"Si","year":"2019","journal-title":"Dye. Pigment."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"16397","DOI":"10.1021\/ja405239v","article-title":"Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer\u2019s Disease","volume":"135","author":"Zhang","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.1073\/pnas.1505420112","article-title":"Near-Infrared Fluorescence Molecular Imaging of Amyloid Beta Species and Monitoring Therapy in Animal Models of Alzheimer\u2019s Disease","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1747-0285.2007.00557.x","article-title":"Structure?Activity Relationships of Amyloid Beta-Aggregation Inhibitors Based on Curcumin: Influence of Linker Length and Flexibility","volume":"70","author":"Reinke","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1002\/chem.201800501","article-title":"Detection and Imaging of A\u03b21-42 and Tau Fibrils by Redesigned Fluorescent X-34 Analogues","volume":"24","author":"Zhang","year":"2018","journal-title":"Chem. Eur. J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1021\/jm1006929","article-title":"Phenolic Bis-Styrylbenzenes as \u03b2-Amyloid Binding Ligands and Free Radical Scavengers","volume":"53","author":"Flaherty","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)00915-1","article-title":"Chrysamine G and Its Derivative Reduce Amyloid \u03b2-Induced Neurotoxicity in Mice","volume":"333","author":"Ishii","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jnen\/61.9.797","article-title":"Imaging A\u03b2 Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy-X04, a Systemically Administered Congo Red Derivative","volume":"61","author":"Klunk","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Zhang, M., Fu, H., Hu, W., Leng, J., and Zhang, Y. (2022). Versatile Dicyanomethylene-Based Fluorescent Probes for the Detection of \u03b2-Amyloid in Alzheimer\u2019s Disease: A Theoretical Perspective. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158619"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1021\/acs.analchem.5b00017","article-title":"In Vivo Detection of Cerebral Amyloid Fibrils with Smart Dicynomethylene-4H-Pyran-Based Fluorescence Probe","volume":"87","author":"Cheng","year":"2015","journal-title":"Anal. Chem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11307-006-0061-4","article-title":"High-Yield, Automated Radiosynthesis of 2-(1-{6-[(2-[18F]Fluoroethyl)(Methyl)Amino]-2-Naphthyl}ethylidene)Malononitrile ([18F]FDDNP) Ready for Animal or Human Administration","volume":"9","author":"Liu","year":"2007","journal-title":"Mol. Imaging Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/anie.201104150","article-title":"Inhibition of Beta-Amyloid Peptide Aggregation by Multifunctional Carbazole-Based Fluorophores","volume":"51","author":"Yang","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1021\/acsomega.8b00475","article-title":"Effective Theranostic Cyanine for Imaging of Amyloid Species in Vivo and Cognitive Improvements in Mouse Model","volume":"3","author":"Li","year":"2018","journal-title":"ACS Omega"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/acschemneuro.6b00380","article-title":"Development of Phenothiazine-Based Theranostic Compounds That Act Both as Inhibitors of \u03b2-Amyloid Aggregation and as Imaging Probes for Amyloid Plaques in Alzheimer\u2019s Disease","volume":"8","author":"Dao","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acschemneuro.2c00468","article-title":"Design of a Coumarin-Based Fluorescent Probe for Efficient In Vivo Imaging of Amyloid-\u03b2 Plaques","volume":"14","author":"Cao","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"119661","DOI":"10.1016\/j.jlumin.2022.119661","article-title":"Application of a Novel Coumarin-Derivative near-Infrared Fluorescence Probe to Amyloid-\u03b2 Imaging and Inhibition in Alzheimer\u2019s Disease","volume":"256","author":"Chen","year":"2023","journal-title":"J. Lumin."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bios.2017.06.030","article-title":"A\u03b2 Plaque-Selective NIR Fluorescence Probe to Differentiate Alzheimer\u2019s Disease from Tauopathies","volume":"98","author":"Rajasekhar","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"9910","DOI":"10.1039\/C7CC05056A","article-title":"Neutral Merocyanine Dyes: For in Vivo NIR Fluorescence Imaging of Amyloid-\u03b2 Plaques","volume":"53","author":"Yan","year":"2017","journal-title":"Chem. Commun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"126903","DOI":"10.1016\/j.snb.2019.126903","article-title":"Dual-Functional Red-Emitting Fluorescent Probes for Imaging Beta-Amyloid Plaques and Viscosity","volume":"298","author":"Tan","year":"2019","journal-title":"Sens. Actuators B Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejmech.2019.07.005","article-title":"A Hemicyanine Derivative for Near-Infrared Imaging of \u03b2-Amyloid Plaques in Alzheimer\u2019s Disease","volume":"179","author":"Yang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM Structures of Tau Filaments from Alzheimer\u2019s Disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.cell.2022.02.026","article-title":"Homotypic Fibrillization of TMEM106B across Diverse Neurodegenerative Diseases","volume":"185","author":"Chang","year":"2022","journal-title":"Cell"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e43584","DOI":"10.7554\/eLife.43584","article-title":"Heparin-Induced Tau Filaments Are Polymorphic and Differ from Those in Alzheimer\u2019s and Pick\u2019s Diseases","volume":"8","author":"Zhang","year":"2019","journal-title":"eLife"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-Based Classification of Tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of Filaments from Pick\u2019s Disease Reveal a Novel Tau Protein Fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","article-title":"Novel Tau Filament Fold in Chronic Traumatic Encephalopathy Encloses Hydrophobic Molecules","volume":"568","author":"Falcon","year":"2019","journal-title":"Nature"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"105645","DOI":"10.1016\/j.isci.2022.105645","article-title":"Subtle Change of Fibrillation Condition Leads to Substantial Alteration of Recombinant Tau Fibril Structure","volume":"25","author":"Li","year":"2022","journal-title":"iScience"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1523\/JNEUROSCI.1738-05.2005","article-title":"Quinoline and Benzimidazole Derivatives: Candidate Probes for In Vivo Imaging of Tau Pathology in Alzheimer\u2019s Disease","volume":"25","author":"Okamura","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","article-title":"18F-THK523: A Novel in Vivo Tau Imaging Ligand for Alzheimer\u2019s Disease","volume":"134","author":"Okamura","year":"2011","journal-title":"Brain"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease","volume":"54","author":"Okamura","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[18F]T807, a Novel Tau Positron Emission Tomography Imaging Agent for Alzheimer\u2019s Disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_164","first-page":"232","article-title":"Tau Positron Emission Tomography Imaging in Tauopathies: The Added Hurdle of Off-target Binding","volume":"10","author":"Lemoine","year":"2018","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1021\/acschemneuro.9b00326","article-title":"Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase","volume":"10","author":"Drake","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/acschemneuro.9b00639","article-title":"Evaluation of [18F]- N -Methyl Lansoprazole as a Tau PET Imaging Agent in First-in-Human Studies","volume":"11","author":"Kramer","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/brain\/awaa180","article-title":"18F-MK-6240 PET for Early and Late Detection of Neurofibrillary Tangles","volume":"143","author":"Pascoal","year":"2020","journal-title":"Brain"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","article-title":"Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles","volume":"57","author":"Hostetler","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and Preclinical Characterization of [18F]PI-2620, a next-Generation Tau PET Tracer for the Assessment of Tau Pathology in Alzheimer\u2019s Disease and Other Tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2967\/jnumed.118.214437","article-title":"Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain","volume":"59","author":"Kuwabara","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2967\/jnumed.117.196741","article-title":"Preclinical Evaluation of 18F-RO6958948, 11C-RO6931643, and 11C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease","volume":"59","author":"Honer","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1021\/acs.jmedchem.8b01759","article-title":"Discovery of N-(4-[18F]Fluoro-5-Methylpyridin-2-Yl)Isoquinolin-6-Amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer","volume":"62","author":"Rombouts","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00259-019-04399-0","article-title":"[18F]GTP1 (Genentech Tau Probe 1), a Radioligand for Detecting Neurofibrillary Tangle Tau Pathology in Alzheimer\u2019s Disease","volume":"46","author":"Marik","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.25060","article-title":"18F-Flortaucipir Tau Positron Emission Tomography Distinguishes Established Progressive Supranuclear Palsy from Controls and Parkinson Disease: A Multicenter Study: Flortaucipir Tau PET in PSP","volume":"82","author":"Schonhaut","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JAD-200287","article-title":"Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation","volume":"76","author":"Su","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-2010-1262","article-title":"Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer\u2019s Disease","volume":"19","author":"Rojo","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.0000000000003001","article-title":"Cerebral Amyloid Angiopathy in Posttransplant Patients with Hereditary ATTR Amyloidosis","volume":"87","author":"Sekijima","year":"2016","journal-title":"Neurology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","article-title":"Visualization of Multiple Organ Amyloid Involvement in Systemic Amyloidosis Using 11C-PiB PET Imaging","volume":"45","author":"Ezawa","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In Vivo Visualization of Amyloid Deposits in the Heart with 11 C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"816636","DOI":"10.3389\/fneur.2022.816636","article-title":"Cerebellar and Cerebral Amyloid Visualized by [18F]Flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors","volume":"13","author":"Uneus","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00259-019-04627-7","article-title":"Quantitative [18F]Florbetapir PET\/CT May Identify Lung Involvement in Patients with Systemic AL Amyloidosis","volume":"47","author":"Khor","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","article-title":"Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET\/CT","volume":"60","author":"Ehman","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-018-0425-1","article-title":"18F-Florbetaben Whole-Body PET\/MRI for Evaluation of Systemic Amyloid Deposition","volume":"8","author":"Baratto","year":"2018","journal-title":"EJNMMI Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1021\/acs.jmedchem.0c00955","article-title":"Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1021\/acs.jmedchem.1c00667","article-title":"[11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins","volume":"64","author":"Liu","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acs.jmedchem.2c01585","article-title":"Design and Evaluation of [18F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular Mechanism of Thioflavin-T Binding to Amyloid Fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Proteins Proteom."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","article-title":"Extrinsic Fluorescent Dyes as Tools for Protein Characterization","volume":"25","author":"Hawe","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bmb\/ldt021","article-title":"Imaging in Systemic Amyloidosis","volume":"107","author":"Sachchithanantham","year":"2013","journal-title":"Br. Med. Bull."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11886-011-0239-5","article-title":"Molecular Imaging of Amyloidosis: Will the Heart Be the Next Target After the Brain?","volume":"14","author":"Chen","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_192","unstructured":"Cheng, K.T. (2004). Molecular Imaging and Contrast Agent Database (MICAD), National Center for Biotechnology Information (US)."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3348\/kjr.2017.18.1.113","article-title":"Myocardial T1 and T2 Mapping: Techniques and Clinical Applications","volume":"18","author":"Kim","year":"2017","journal-title":"Korean J. Radiol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4329\/wjr.v12.i6.87","article-title":"Multi-Modality Imaging of Cardiac Amyloidosis: Contemporary Update","volume":"12","author":"Wang","year":"2020","journal-title":"World J. Radiol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.matpr.2020.03.189","article-title":"Early Detection of Alzheimer Disease Using Gadolinium Material","volume":"45","author":"Soundarya","year":"2021","journal-title":"Mater. Today Proc."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"12419","DOI":"10.1038\/s41598-021-91899-5","article-title":"In Vivo Multi-Parametric Manganese-Enhanced MRI for Detecting Amyloid Plaques in Rodent Models of Alzheimer\u2019s Disease","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"14461","DOI":"10.1039\/C7DT02371E","article-title":"Metal Complexes for Multimodal Imaging of Misfolded Protein-Related Diseases","volume":"46","author":"Lacerda","year":"2017","journal-title":"Dalton Trans."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/nbdi.2002.0550","article-title":"Molecular Targeting of Alzheimer\u2019s Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging","volume":"11","author":"Poduslo","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1021\/bi0359574","article-title":"Design and Chemical Synthesis of a Magnetic Resonance Contrast Agent with Enhanced in Vitro Binding, High Blood\u2212Brain Barrier Permeability, and in Vivo Targeting to Alzheimer\u2019s Disease Amyloid Plaques","volume":"43","author":"Poduslo","year":"2004","journal-title":"Biochemistry"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.npep.2015.07.001","article-title":"Gadolinium-Complexed A\u03b2-Binding Contrast Agents for MRI Diagnosis of Alzheimer\u2019s Disease","volume":"53","author":"Matharu","year":"2015","journal-title":"Neuropeptides"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12951-016-0212-y","article-title":"Gd-Nanoparticles Functionalization with Specific Peptides for \u00df-Amyloid Plaques Targeting","volume":"14","author":"Plissonneau","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Wadghiri, Y.Z., Li, J., Wang, J., Hoang, D.M., Sun, Y., Xu, H., Tsui, W., Li, Y., Boutajangout, A., and Wang, A. (2013). Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer\u2019s Disease Transgenic Mice Using Magnetic Resonance Microimaging. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057097"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/IJN.S351830","article-title":"Amyloid Plaque Imaging with a Targeted MRI Contrast Agent in a Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"17","author":"Xiong","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/cn200028j","article-title":"Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer\u2019s Disease in Vitro","volume":"2","author":"Yang","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04591.x","article-title":"In Vivo Targeting of Antibody Fragments to the Nervous System for Alzheimer\u2019s Disease Immunotherapy and Molecular Imaging of Amyloid Plaques: Targeting of Antibody Fragments to AD Amyloid Plaques","volume":"102","author":"Poduslo","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/19420862.2017.1342914","article-title":"Chemically-Defined Camelid Antibody Bioconjugate for the Magnetic Resonance Imaging of Alzheimer\u2019s Disease","volume":"9","author":"Vandesquille","year":"2017","journal-title":"mAbs"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-121171","article-title":"SPION-Enhanced Magnetic Resonance Imaging of Alzheimer\u2019s Disease Plaques in A\u03b2PP\/PS-1 Transgenic Mouse Brain","volume":"34","author":"Sillerud","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.2147\/IJN.S52833","article-title":"Antibody-Conjugated, Dual-Modal, near-Infrared Fluorescent Iron Oxide Nanoparticles for Antiamyloidgenic Activity and Specific Detection of Amyloid-\u03b2; Fibrils","volume":"8","author":"Margel","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jiec.2019.11.031","article-title":"Multifunctional Imaging of Amyloid-Beta Peptides with a New Gadolinium-Based Contrast Agent in Alzheimer\u2019s Disease","volume":"83","author":"Choi","year":"2020","journal-title":"J. Ind. Eng. Chem."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.1021\/acsami.1c01585","article-title":"Multimodal Theranostic Cyanine-Conjugated Gadolinium(III) Complex for In Vivo Imaging of Amyloid-\u03b2 in an Alzheimer\u2019s Disease Mouse Model","volume":"13","author":"Wang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1039\/D2RA00614F","article-title":"Development of an MRI Contrast Agent for Both Detection and Inhibition of the Amyloid-\u03b2 Fibrillation Process","volume":"12","author":"Utomo","year":"2022","journal-title":"RSC Adv."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/ml400042w","article-title":"PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of \u03b2-Amyloid Plaques","volume":"4","author":"Martins","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00775-013-1055-8","article-title":"Gd3+ Complexes Conjugated to Pittsburgh Compound B: Potential MRI Markers of \u03b2-Amyloid Plaques","volume":"19","author":"Martins","year":"2014","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biomaterials.2014.12.005","article-title":"Curcumin-Conjugated Magnetic Nanoparticles for Detecting Amyloid Plaques in Alzheimer\u2019s Disease Mice Using Magnetic Resonance Imaging (MRI)","volume":"44","author":"Cheng","year":"2015","journal-title":"Biomaterials"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.msec.2014.01.005","article-title":"Synthesis of Superparamagnetic Iron Oxide Nanoparticles Coated with a DDNP-Carboxyl Derivative for in Vitro Magnetic Resonance Imaging of Alzheimer\u2019s Disease","volume":"37","author":"Zhou","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/ar.21209","article-title":"Detection of A\u03b2 Plaques by a Novel Specific MRI Probe Precursor CR-BSA-(Gd-DTPA)n in APP\/PS1 Transgenic Mice","volume":"293","author":"Li","year":"2010","journal-title":"Anat. Rec."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Sedov, I., and Khaibrakhmanova, D. (2022). Molecular Mechanisms of Inhibition of Protein Amyloid Fibril Formation: Evidence and Perspectives Based on Kinetic Models. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113428"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1909529","DOI":"10.1002\/adfm.201909529","article-title":"Amyloid-\u03b2 Oligomer-Targeted Gadolinium-Based NIR\/MR Dual-Modal Theranostic Nanoprobe for Alzheimer\u2019s Disease","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"16185","DOI":"10.1038\/s41598-020-73233-7","article-title":"Pre-Clinical Dose-Ranging Efficacy, Pharmacokinetics, Tissue Biodistribution, and Toxicity of a Targeted Contrast Agent for MRI of Amyloid Deposition in Alzheimer\u2019s Disease","volume":"10","author":"Badachhape","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1007\/s11095-008-9688-y","article-title":"Development of a Smart Nano-Vehicle to Target Cerebrovascular Amyloid Deposits and Brain Parenchymal Plaques Observed in Alzheimer\u2019s Disease and Cerebral Amyloid Angiopathy","volume":"25","author":"Agyare","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cmmi.1626","article-title":"In Vitro and in Vivo Characterization of Several Functionalized Ultrasmall Particles of Iron Oxide, Vectorized against Amyloid Plaques and Potentially Able to Cross the Blood-Brain Barrier: Toward Earlier Diagnosis of Alzheimer\u2019s Disease by Molecular Imag: Molecular Contrast Agents for Alzheimer\u2019s Disease","volume":"10","author":"Ansciaux","year":"2015","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_223","unstructured":"Alzeca Biosciences, Inc (2022). Proof-of-Concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer\u2019s Disease, Alzeca Biosciences, Inc."},{"key":"ref_224","unstructured":"Tanifum, E.A., Ghaghada, K.B., and Annapragada, A.V. (2021). Targeted Contrast Agents for MRI of Amyloid Deposition. (11116854B2), U.S. Patent."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11152\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:07:12Z","timestamp":1760126832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":224,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241311152"],"URL":"https:\/\/doi.org\/10.3390\/ijms241311152","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}